HB1082Introduced in the House
Shandra Eisenga Human Cell and Tissue Product Safety Act
Introduced by John Moolenaar, District MI-2
What does this bill do?
Plain-English breakdown
Checking for a plain-English summary…
Official description
To require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants, and for other purposes.
Where it stands
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
June 24, 2025
How did lawmakers vote?
No recorded vote is available for this bill yet.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
Bill history
Introduced in House
Referred to the House Committee on Energy and Commerce.
Committee Consideration and Mark-up Session Held
Ordered to be Reported by Voice Vote.
Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
Placed on the Union Calendar, Calendar No. 127.
Mr. Bilirakis moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H2860-2862)
DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.